MedPath

Comparison of two radiotherapy types- only PELVIC and EXTENDED in cervical cancer patients

Phase 3
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Registration Number
CTRI/2024/08/071920
Lead Sponsor
SAIMS Indore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Biopsy proven Carcinoma cervix (squamous, adeno or adeno-squamous) stage III (IIIA, IIIB, IIIc1)

Karnoffsky performance status more than 70.Normal Hemogram-Hemoglobinmore than8 g/dl, Total Leukocyte count more than 4,000 cells/mm3, Absolute neutrophil count more than 1500 cells/mm3, Platelet count more than 100000 cells/mm3.Normal liver and kidney function tests (urea less than 40, Creatinine less than 1.2 mg/dl).Negative pregnancy test for women of child bearing potential.Willing to sign the written informed consent prior to study.No other synchronous malignancy

Exclusion Criteria

1. Positive para-aortic LN’s on imaging (i.e. stage IIIC2)

2. Uncontrolled diabetes or hypertension

3. Previous history of receiving radiotherapy

4. Underwent surgical management for carcinoma cervix

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath